Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOPE real-world study of Humira for active non-infectious intermediate, posterior, or panuveitis
MOH_2017-05-08_000385Phase 4Completed
- Sponsor
- AbbVie Inc.
- Start
- Mar 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adalimumab in noninfectious uveitis (NIU), sponsored by AbbVie Inc. Started Mar 2017; status: completed.
02
Drugs
03
Conditions
noninfectious uveitis (NIU)
Beyond the preview
Go deeper on MOH_2017-05-08_000385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-05-08_000385.